TY - JOUR
T1 - Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction
T2 - Associated clinical findings and early prognosis
AU - Hong, Robert A.
AU - Licht, Jonathan D.
AU - Wei, Jeanne Y.
AU - Heller, Gary V.
AU - Blaustein, Alvin S.
AU - Pasternak, Richard C.
N1 - Funding Information:
From the Charles A. Dana Research Institute, and the Harvard-Thorndike Laboratory of the Beth Israel Hospital, Department of Medicine, Beth Israel Hospital, and Harvard Medical School. Supported in part by United States Public Health Service grant RR-01032 from the General Clinical Research Centers Program of the Division of Research Resources, HL29295, National Heart, Lung, and Blood Institute, and the Veterans Administration.
PY - 1986/6
Y1 - 1986/6
N2 - To test the hypothesis that patients with normal serum levels of creatine kinase (CK) but elevated percentages of MB isoenzyme fractions in suspected myocardial infarction may have sustained clinically significant events, we studied the hospital course of 347 consecutive patients admitted with suspected myocardial infarction. Two hundred twenty-three patients had normal CK levels (182 ± 44 IU) and normal MB percentages (normal group), 68 had elevated levels of both CK (1395 ± 178 IU) and MB percentage (10.5 ± 0.6) (macroinfarction group), and 40 had normal CK levels (96 ± 7 IU) but elevated MB percentages (9.6 ± 0.5) with typical enzyme curves (macroinfarction group). Compared to the normal group, macroinfarction patients were older, had more congestive heart failure, required more intensive monitoring and therapy during longer stays, and sustained a higher in-hospital mortality rate. Thus, these macroinfarction patients are at increased risk and therefore warrant aggressive treatment and further evaluation.
AB - To test the hypothesis that patients with normal serum levels of creatine kinase (CK) but elevated percentages of MB isoenzyme fractions in suspected myocardial infarction may have sustained clinically significant events, we studied the hospital course of 347 consecutive patients admitted with suspected myocardial infarction. Two hundred twenty-three patients had normal CK levels (182 ± 44 IU) and normal MB percentages (normal group), 68 had elevated levels of both CK (1395 ± 178 IU) and MB percentage (10.5 ± 0.6) (macroinfarction group), and 40 had normal CK levels (96 ± 7 IU) but elevated MB percentages (9.6 ± 0.5) with typical enzyme curves (macroinfarction group). Compared to the normal group, macroinfarction patients were older, had more congestive heart failure, required more intensive monitoring and therapy during longer stays, and sustained a higher in-hospital mortality rate. Thus, these macroinfarction patients are at increased risk and therefore warrant aggressive treatment and further evaluation.
UR - http://www.scopus.com/inward/record.url?scp=0022483287&partnerID=8YFLogxK
U2 - 10.1016/0002-8703(86)90004-9
DO - 10.1016/0002-8703(86)90004-9
M3 - Article
C2 - 3716977
AN - SCOPUS:0022483287
SN - 0002-8703
VL - 111
SP - 1041
EP - 1047
JO - American Heart Journal
JF - American Heart Journal
IS - 6
ER -